Global Human Gene Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 121

Published Date: 06 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Human Gene Therapy market size was valued at USD 5163.5 million in 2022 and is forecast to a readjusted size of USD 7778.9 million by 2029 with a CAGR of 6.0% during review period.

Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.

Advances in gene therapy technology, increasing understanding of genetics, and the potential for addressing previously untreatable diseases contribute to the growth of the Human Gene Therapy market.

The Global Info Research report includes an overview of the development of the Human Gene Therapy industry chain, the market status of Neurological Diseases (Non-viral Vectors, Viral Vectors), Cancer (Non-viral Vectors, Viral Vectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Gene Therapy.

Regionally, the report analyzes the Human Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Human Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Gene Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Non-viral Vectors, Viral Vectors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Gene Therapy market.

Regional Analysis: The report involves examining the Human Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Human Gene Therapy:
Company Analysis: Report covers individual Human Gene Therapy manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neurological Diseases, Cancer).

Technology Analysis: Report covers specific technologies relevant to Human Gene Therapy. It assesses the current state, advancements, and potential future developments in Human Gene Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Human Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Non-viral Vectors
Viral Vectors

Market segment by Application
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others

Major players covered
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Gene Therapy, with price, sales, revenue and global market share of Human Gene Therapy from 2018 to 2023.
Chapter 3, the Human Gene Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Gene Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Gene Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Gene Therapy.
Chapter 14 and 15, to describe Human Gene Therapy sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Human Gene Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Human Gene Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Non-viral Vectors
        1.3.3 Viral Vectors
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Human Gene Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Neurological Diseases
        1.4.3 Cancer
        1.4.4 DMD (Duchenne Muscular Dystrophy)
        1.4.5 Hepatological Diseases
        1.4.6 Others
    1.5 Global Human Gene Therapy Market Size & Forecast
        1.5.1 Global Human Gene Therapy Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Human Gene Therapy Sales Quantity (2018-2029)
        1.5.3 Global Human Gene Therapy Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Human Gene Therapy Product and Services
        2.1.4 Biogen Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Biogen Recent Developments/Updates
    2.2 Sarepta Therapeutics
        2.2.1 Sarepta Therapeutics Details
        2.2.2 Sarepta Therapeutics Major Business
        2.2.3 Sarepta Therapeutics Human Gene Therapy Product and Services
        2.2.4 Sarepta Therapeutics Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Sarepta Therapeutics Recent Developments/Updates
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Human Gene Therapy Product and Services
        2.3.4 Gilead Sciences Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Gilead Sciences Recent Developments/Updates
    2.4 Amgen
        2.4.1 Amgen Details
        2.4.2 Amgen Major Business
        2.4.3 Amgen Human Gene Therapy Product and Services
        2.4.4 Amgen Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Amgen Recent Developments/Updates
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Human Gene Therapy Product and Services
        2.5.4 Novartis Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Novartis Recent Developments/Updates
    2.6 Orchard Therapeutics
        2.6.1 Orchard Therapeutics Details
        2.6.2 Orchard Therapeutics Major Business
        2.6.3 Orchard Therapeutics Human Gene Therapy Product and Services
        2.6.4 Orchard Therapeutics Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Orchard Therapeutics Recent Developments/Updates
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Human Gene Therapy Product and Services
        2.7.4 Spark Therapeutics Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Spark Therapeutics Recent Developments/Updates
    2.8 Agc Biologics
        2.8.1 Agc Biologics Details
        2.8.2 Agc Biologics Major Business
        2.8.3 Agc Biologics Human Gene Therapy Product and Services
        2.8.4 Agc Biologics Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Agc Biologics Recent Developments/Updates
    2.9 Anges
        2.9.1 Anges Details
        2.9.2 Anges Major Business
        2.9.3 Anges Human Gene Therapy Product and Services
        2.9.4 Anges Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Anges Recent Developments/Updates
    2.10 Bluebird Bio
        2.10.1 Bluebird Bio Details
        2.10.2 Bluebird Bio Major Business
        2.10.3 Bluebird Bio Human Gene Therapy Product and Services
        2.10.4 Bluebird Bio Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Bluebird Bio Recent Developments/Updates
    2.11 Jazz Pharmaceuticals
        2.11.1 Jazz Pharmaceuticals Details
        2.11.2 Jazz Pharmaceuticals Major Business
        2.11.3 Jazz Pharmaceuticals Human Gene Therapy Product and Services
        2.11.4 Jazz Pharmaceuticals Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Jazz Pharmaceuticals Recent Developments/Updates
    2.12 Dynavax Technologies
        2.12.1 Dynavax Technologies Details
        2.12.2 Dynavax Technologies Major Business
        2.12.3 Dynavax Technologies Human Gene Therapy Product and Services
        2.12.4 Dynavax Technologies Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Dynavax Technologies Recent Developments/Updates
    2.13 Human Stem Cells Institute
        2.13.1 Human Stem Cells Institute Details
        2.13.2 Human Stem Cells Institute Major Business
        2.13.3 Human Stem Cells Institute Human Gene Therapy Product and Services
        2.13.4 Human Stem Cells Institute Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Human Stem Cells Institute Recent Developments/Updates
    2.14 Sibiono Genetech
        2.14.1 Sibiono Genetech Details
        2.14.2 Sibiono Genetech Major Business
        2.14.3 Sibiono Genetech Human Gene Therapy Product and Services
        2.14.4 Sibiono Genetech Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Sibiono Genetech Recent Developments/Updates
    2.15 Shanghai Sunway Biotech
        2.15.1 Shanghai Sunway Biotech Details
        2.15.2 Shanghai Sunway Biotech Major Business
        2.15.3 Shanghai Sunway Biotech Human Gene Therapy Product and Services
        2.15.4 Shanghai Sunway Biotech Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Shanghai Sunway Biotech Recent Developments/Updates
    2.16 Uniqure N.V.
        2.16.1 Uniqure N.V. Details
        2.16.2 Uniqure N.V. Major Business
        2.16.3 Uniqure N.V. Human Gene Therapy Product and Services
        2.16.4 Uniqure N.V. Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Uniqure N.V. Recent Developments/Updates
    2.17 Gensight Biologics S.A.
        2.17.1 Gensight Biologics S.A. Details
        2.17.2 Gensight Biologics S.A. Major Business
        2.17.3 Gensight Biologics S.A. Human Gene Therapy Product and Services
        2.17.4 Gensight Biologics S.A. Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Gensight Biologics S.A. Recent Developments/Updates
    2.18 Celgene Corporation
        2.18.1 Celgene Corporation Details
        2.18.2 Celgene Corporation Major Business
        2.18.3 Celgene Corporation Human Gene Therapy Product and Services
        2.18.4 Celgene Corporation Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Celgene Corporation Recent Developments/Updates
    2.19 Cellectis
        2.19.1 Cellectis Details
        2.19.2 Cellectis Major Business
        2.19.3 Cellectis Human Gene Therapy Product and Services
        2.19.4 Cellectis Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 Cellectis Recent Developments/Updates
    2.20 Sangamo Therapeutics
        2.20.1 Sangamo Therapeutics Details
        2.20.2 Sangamo Therapeutics Major Business
        2.20.3 Sangamo Therapeutics Human Gene Therapy Product and Services
        2.20.4 Sangamo Therapeutics Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Sangamo Therapeutics Recent Developments/Updates
    2.21 Mustang Bio
        2.21.1 Mustang Bio Details
        2.21.2 Mustang Bio Major Business
        2.21.3 Mustang Bio Human Gene Therapy Product and Services
        2.21.4 Mustang Bio Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.21.5 Mustang Bio Recent Developments/Updates
    2.22 AGTC
        2.22.1 AGTC Details
        2.22.2 AGTC Major Business
        2.22.3 AGTC Human Gene Therapy Product and Services
        2.22.4 AGTC Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.22.5 AGTC Recent Developments/Updates
    2.23 Poseida Therapeutics
        2.23.1 Poseida Therapeutics Details
        2.23.2 Poseida Therapeutics Major Business
        2.23.3 Poseida Therapeutics Human Gene Therapy Product and Services
        2.23.4 Poseida Therapeutics Human Gene Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.23.5 Poseida Therapeutics Recent Developments/Updates

3 Competitive Environment: Human Gene Therapy by Manufacturer
    3.1 Global Human Gene Therapy Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Human Gene Therapy Revenue by Manufacturer (2018-2023)
    3.3 Global Human Gene Therapy Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Human Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Human Gene Therapy Manufacturer Market Share in 2022
        3.4.2 Top 6 Human Gene Therapy Manufacturer Market Share in 2022
    3.5 Human Gene Therapy Market: Overall Company Footprint Analysis
        3.5.1 Human Gene Therapy Market: Region Footprint
        3.5.2 Human Gene Therapy Market: Company Product Type Footprint
        3.5.3 Human Gene Therapy Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Human Gene Therapy Market Size by Region
        4.1.1 Global Human Gene Therapy Sales Quantity by Region (2018-2029)
        4.1.2 Global Human Gene Therapy Consumption Value by Region (2018-2029)
        4.1.3 Global Human Gene Therapy Average Price by Region (2018-2029)
    4.2 North America Human Gene Therapy Consumption Value (2018-2029)
    4.3 Europe Human Gene Therapy Consumption Value (2018-2029)
    4.4 Asia-Pacific Human Gene Therapy Consumption Value (2018-2029)
    4.5 South America Human Gene Therapy Consumption Value (2018-2029)
    4.6 Middle East and Africa Human Gene Therapy Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Human Gene Therapy Sales Quantity by Type (2018-2029)
    5.2 Global Human Gene Therapy Consumption Value by Type (2018-2029)
    5.3 Global Human Gene Therapy Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Human Gene Therapy Sales Quantity by Application (2018-2029)
    6.2 Global Human Gene Therapy Consumption Value by Application (2018-2029)
    6.3 Global Human Gene Therapy Average Price by Application (2018-2029)

7 North America
    7.1 North America Human Gene Therapy Sales Quantity by Type (2018-2029)
    7.2 North America Human Gene Therapy Sales Quantity by Application (2018-2029)
    7.3 North America Human Gene Therapy Market Size by Country
        7.3.1 North America Human Gene Therapy Sales Quantity by Country (2018-2029)
        7.3.2 North America Human Gene Therapy Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Human Gene Therapy Sales Quantity by Type (2018-2029)
    8.2 Europe Human Gene Therapy Sales Quantity by Application (2018-2029)
    8.3 Europe Human Gene Therapy Market Size by Country
        8.3.1 Europe Human Gene Therapy Sales Quantity by Country (2018-2029)
        8.3.2 Europe Human Gene Therapy Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Human Gene Therapy Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Human Gene Therapy Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Human Gene Therapy Market Size by Region
        9.3.1 Asia-Pacific Human Gene Therapy Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Human Gene Therapy Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Human Gene Therapy Sales Quantity by Type (2018-2029)
    10.2 South America Human Gene Therapy Sales Quantity by Application (2018-2029)
    10.3 South America Human Gene Therapy Market Size by Country
        10.3.1 South America Human Gene Therapy Sales Quantity by Country (2018-2029)
        10.3.2 South America Human Gene Therapy Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Human Gene Therapy Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Human Gene Therapy Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Human Gene Therapy Market Size by Country
        11.3.1 Middle East & Africa Human Gene Therapy Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Human Gene Therapy Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Human Gene Therapy Market Drivers
    12.2 Human Gene Therapy Market Restraints
    12.3 Human Gene Therapy Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Human Gene Therapy and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Human Gene Therapy
    13.3 Human Gene Therapy Production Process
    13.4 Human Gene Therapy Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Human Gene Therapy Typical Distributors
    14.3 Human Gene Therapy Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Human Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Biogen Basic Information, Manufacturing Base and Competitors
    Table 4. Biogen Major Business
    Table 5. Biogen Human Gene Therapy Product and Services
    Table 6. Biogen Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Biogen Recent Developments/Updates
    Table 8. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 9. Sarepta Therapeutics Major Business
    Table 10. Sarepta Therapeutics Human Gene Therapy Product and Services
    Table 11. Sarepta Therapeutics Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Sarepta Therapeutics Recent Developments/Updates
    Table 13. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 14. Gilead Sciences Major Business
    Table 15. Gilead Sciences Human Gene Therapy Product and Services
    Table 16. Gilead Sciences Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Gilead Sciences Recent Developments/Updates
    Table 18. Amgen Basic Information, Manufacturing Base and Competitors
    Table 19. Amgen Major Business
    Table 20. Amgen Human Gene Therapy Product and Services
    Table 21. Amgen Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Amgen Recent Developments/Updates
    Table 23. Novartis Basic Information, Manufacturing Base and Competitors
    Table 24. Novartis Major Business
    Table 25. Novartis Human Gene Therapy Product and Services
    Table 26. Novartis Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Novartis Recent Developments/Updates
    Table 28. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 29. Orchard Therapeutics Major Business
    Table 30. Orchard Therapeutics Human Gene Therapy Product and Services
    Table 31. Orchard Therapeutics Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Orchard Therapeutics Recent Developments/Updates
    Table 33. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 34. Spark Therapeutics Major Business
    Table 35. Spark Therapeutics Human Gene Therapy Product and Services
    Table 36. Spark Therapeutics Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Spark Therapeutics Recent Developments/Updates
    Table 38. Agc Biologics Basic Information, Manufacturing Base and Competitors
    Table 39. Agc Biologics Major Business
    Table 40. Agc Biologics Human Gene Therapy Product and Services
    Table 41. Agc Biologics Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Agc Biologics Recent Developments/Updates
    Table 43. Anges Basic Information, Manufacturing Base and Competitors
    Table 44. Anges Major Business
    Table 45. Anges Human Gene Therapy Product and Services
    Table 46. Anges Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Anges Recent Developments/Updates
    Table 48. Bluebird Bio Basic Information, Manufacturing Base and Competitors
    Table 49. Bluebird Bio Major Business
    Table 50. Bluebird Bio Human Gene Therapy Product and Services
    Table 51. Bluebird Bio Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Bluebird Bio Recent Developments/Updates
    Table 53. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 54. Jazz Pharmaceuticals Major Business
    Table 55. Jazz Pharmaceuticals Human Gene Therapy Product and Services
    Table 56. Jazz Pharmaceuticals Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Jazz Pharmaceuticals Recent Developments/Updates
    Table 58. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
    Table 59. Dynavax Technologies Major Business
    Table 60. Dynavax Technologies Human Gene Therapy Product and Services
    Table 61. Dynavax Technologies Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Dynavax Technologies Recent Developments/Updates
    Table 63. Human Stem Cells Institute Basic Information, Manufacturing Base and Competitors
    Table 64. Human Stem Cells Institute Major Business
    Table 65. Human Stem Cells Institute Human Gene Therapy Product and Services
    Table 66. Human Stem Cells Institute Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Human Stem Cells Institute Recent Developments/Updates
    Table 68. Sibiono Genetech Basic Information, Manufacturing Base and Competitors
    Table 69. Sibiono Genetech Major Business
    Table 70. Sibiono Genetech Human Gene Therapy Product and Services
    Table 71. Sibiono Genetech Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Sibiono Genetech Recent Developments/Updates
    Table 73. Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
    Table 74. Shanghai Sunway Biotech Major Business
    Table 75. Shanghai Sunway Biotech Human Gene Therapy Product and Services
    Table 76. Shanghai Sunway Biotech Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Shanghai Sunway Biotech Recent Developments/Updates
    Table 78. Uniqure N.V. Basic Information, Manufacturing Base and Competitors
    Table 79. Uniqure N.V. Major Business
    Table 80. Uniqure N.V. Human Gene Therapy Product and Services
    Table 81. Uniqure N.V. Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Uniqure N.V. Recent Developments/Updates
    Table 83. Gensight Biologics S.A. Basic Information, Manufacturing Base and Competitors
    Table 84. Gensight Biologics S.A. Major Business
    Table 85. Gensight Biologics S.A. Human Gene Therapy Product and Services
    Table 86. Gensight Biologics S.A. Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. Gensight Biologics S.A. Recent Developments/Updates
    Table 88. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 89. Celgene Corporation Major Business
    Table 90. Celgene Corporation Human Gene Therapy Product and Services
    Table 91. Celgene Corporation Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 92. Celgene Corporation Recent Developments/Updates
    Table 93. Cellectis Basic Information, Manufacturing Base and Competitors
    Table 94. Cellectis Major Business
    Table 95. Cellectis Human Gene Therapy Product and Services
    Table 96. Cellectis Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 97. Cellectis Recent Developments/Updates
    Table 98. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 99. Sangamo Therapeutics Major Business
    Table 100. Sangamo Therapeutics Human Gene Therapy Product and Services
    Table 101. Sangamo Therapeutics Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 102. Sangamo Therapeutics Recent Developments/Updates
    Table 103. Mustang Bio Basic Information, Manufacturing Base and Competitors
    Table 104. Mustang Bio Major Business
    Table 105. Mustang Bio Human Gene Therapy Product and Services
    Table 106. Mustang Bio Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Mustang Bio Recent Developments/Updates
    Table 108. AGTC Basic Information, Manufacturing Base and Competitors
    Table 109. AGTC Major Business
    Table 110. AGTC Human Gene Therapy Product and Services
    Table 111. AGTC Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 112. AGTC Recent Developments/Updates
    Table 113. Poseida Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 114. Poseida Therapeutics Major Business
    Table 115. Poseida Therapeutics Human Gene Therapy Product and Services
    Table 116. Poseida Therapeutics Human Gene Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 117. Poseida Therapeutics Recent Developments/Updates
    Table 118. Global Human Gene Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 119. Global Human Gene Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 120. Global Human Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 121. Market Position of Manufacturers in Human Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 122. Head Office and Human Gene Therapy Production Site of Key Manufacturer
    Table 123. Human Gene Therapy Market: Company Product Type Footprint
    Table 124. Human Gene Therapy Market: Company Product Application Footprint
    Table 125. Human Gene Therapy New Market Entrants and Barriers to Market Entry
    Table 126. Human Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 127. Global Human Gene Therapy Sales Quantity by Region (2018-2023) & (K Units)
    Table 128. Global Human Gene Therapy Sales Quantity by Region (2024-2029) & (K Units)
    Table 129. Global Human Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 130. Global Human Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 131. Global Human Gene Therapy Average Price by Region (2018-2023) & (US$/Unit)
    Table 132. Global Human Gene Therapy Average Price by Region (2024-2029) & (US$/Unit)
    Table 133. Global Human Gene Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 134. Global Human Gene Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 135. Global Human Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 136. Global Human Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 137. Global Human Gene Therapy Average Price by Type (2018-2023) & (US$/Unit)
    Table 138. Global Human Gene Therapy Average Price by Type (2024-2029) & (US$/Unit)
    Table 139. Global Human Gene Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 140. Global Human Gene Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 141. Global Human Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 142. Global Human Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 143. Global Human Gene Therapy Average Price by Application (2018-2023) & (US$/Unit)
    Table 144. Global Human Gene Therapy Average Price by Application (2024-2029) & (US$/Unit)
    Table 145. North America Human Gene Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 146. North America Human Gene Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 147. North America Human Gene Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 148. North America Human Gene Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 149. North America Human Gene Therapy Sales Quantity by Country (2018-2023) & (K Units)
    Table 150. North America Human Gene Therapy Sales Quantity by Country (2024-2029) & (K Units)
    Table 151. North America Human Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 152. North America Human Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 153. Europe Human Gene Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 154. Europe Human Gene Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 155. Europe Human Gene Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 156. Europe Human Gene Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 157. Europe Human Gene Therapy Sales Quantity by Country (2018-2023) & (K Units)
    Table 158. Europe Human Gene Therapy Sales Quantity by Country (2024-2029) & (K Units)
    Table 159. Europe Human Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 160. Europe Human Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 161. Asia-Pacific Human Gene Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 162. Asia-Pacific Human Gene Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 163. Asia-Pacific Human Gene Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 164. Asia-Pacific Human Gene Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 165. Asia-Pacific Human Gene Therapy Sales Quantity by Region (2018-2023) & (K Units)
    Table 166. Asia-Pacific Human Gene Therapy Sales Quantity by Region (2024-2029) & (K Units)
    Table 167. Asia-Pacific Human Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 168. Asia-Pacific Human Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 169. South America Human Gene Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 170. South America Human Gene Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 171. South America Human Gene Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 172. South America Human Gene Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 173. South America Human Gene Therapy Sales Quantity by Country (2018-2023) & (K Units)
    Table 174. South America Human Gene Therapy Sales Quantity by Country (2024-2029) & (K Units)
    Table 175. South America Human Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 176. South America Human Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 177. Middle East & Africa Human Gene Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 178. Middle East & Africa Human Gene Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 179. Middle East & Africa Human Gene Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 180. Middle East & Africa Human Gene Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 181. Middle East & Africa Human Gene Therapy Sales Quantity by Region (2018-2023) & (K Units)
    Table 182. Middle East & Africa Human Gene Therapy Sales Quantity by Region (2024-2029) & (K Units)
    Table 183. Middle East & Africa Human Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 184. Middle East & Africa Human Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 185. Human Gene Therapy Raw Material
    Table 186. Key Manufacturers of Human Gene Therapy Raw Materials
    Table 187. Human Gene Therapy Typical Distributors
    Table 188. Human Gene Therapy Typical Customers
List of Figures
    Figure 1. Human Gene Therapy Picture
    Figure 2. Global Human Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Human Gene Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Non-viral Vectors Examples
    Figure 5. Viral Vectors Examples
    Figure 6. Global Human Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Human Gene Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Neurological Diseases Examples
    Figure 9. Cancer Examples
    Figure 10. DMD (Duchenne Muscular Dystrophy) Examples
    Figure 11. Hepatological Diseases Examples
    Figure 12. Others Examples
    Figure 13. Global Human Gene Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Human Gene Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Human Gene Therapy Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Human Gene Therapy Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Human Gene Therapy Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Human Gene Therapy Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Human Gene Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Human Gene Therapy Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Human Gene Therapy Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Human Gene Therapy Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Human Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Human Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Human Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Human Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Human Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Human Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Human Gene Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Human Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Human Gene Therapy Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Human Gene Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Human Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Human Gene Therapy Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Human Gene Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Human Gene Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Human Gene Therapy Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Human Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Human Gene Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Human Gene Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Human Gene Therapy Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Human Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Human Gene Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Human Gene Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Human Gene Therapy Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Human Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Human Gene Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Human Gene Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Human Gene Therapy Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Human Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Human Gene Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Human Gene Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Human Gene Therapy Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Human Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Human Gene Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Human Gene Therapy Market Drivers
    Figure 76. Human Gene Therapy Market Restraints
    Figure 77. Human Gene Therapy Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Human Gene Therapy in 2022
    Figure 80. Manufacturing Process Analysis of Human Gene Therapy
    Figure 81. Human Gene Therapy Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics

Related Reports

Global Human Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Human Gene Therapy Supply, Demand and Key Producers, 2023-2029

date 06 Sep 2023

date Pharma & Healthcare

The global Human Gene Therapy market size is expected to reach $ 7778.9 million by 2029, rising at a market growth of 6.0% CAGR during the forecast period (2023-2029).

Global Human Gene Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Gene Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Gene Therapy market size was valued at USD 5163.5 million in 2023 and is forecast to a readjusted size of USD 7778.9 million by 2030 with a CAGR of 6.0% during review period.

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>